Article
Tumor-naïve ctDNA detection with deep learning-enhanced error suppression for sensitive mutation calling.
Genome medicine - 23 Jun 2026
Akbarinejad Shaya, Doppler Sarah, Graaf Jos de, Pistolic-Kraft Jelena, Bukur Valesca, Albrecht Christian, Buchholz Nathalie, Özenoglu Simge, Sahin Ugur, Ibn-Salem Jonas, Weber David
Abstract excerpt
BACKGROUND: Circulating tumor DNA (ctDNA) detection offers minimally invasive monitoring of cancer from blood samples. While tumor-informed approaches are sensitive, their clinical application is limited by cost, tissue availability, and turnaround time. In contrast, tumor-naïve assays offer faster turnaround times and broader applicability, but often sacrifice sensitivity. METHODS: Here, we developed DEEPctMUT,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
